-transparent.png){kind=logo}
Follow-up studies of antibody-titres in patients suffering from recidivations of herpes labialis and progenitalis treated with herpes virus vaccine inactivated by heat. It was stated by several authors that patients suffering from recidivations of herpes labialis and progenitalis can be successfully treated with a herpes virus vaccine inactivated by heat (Lupidon G/H). Nothing is known, however, about the mechanisms diminishing recurrences. We have studied 11 patients and 3 control persons whether there were changes in specific antibody titres after repeated vaccinations. Skin reactions following intradermal injections were also tested. Serum samples studied over a period of 8 weeks until 9 months showed that the antibody titres found by complement-fixation and neutralization tests remained practically constant. Skin tests were always negative. Therefore it merits further study to find out the mode of action of this clinically successful treatment.
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
January 2017,
The Journal of dermatology,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
April 1984,
Annals of internal medicine,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
February 1981,
Immunology today,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
March 1986,
The New England journal of medicine,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
March 1986,
The New England journal of medicine,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
September 1975,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
July 1973,
Zeitschrift fur Hautkrankheiten,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
July 2009,
Pain,
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
March 1959,
Science (New York, N.Y.),
W Remy, and
G Antoniadis, and
H Bockendahl, and
B Remy
February 1987,
Journal of virology,
